Additional Valsartan/HCTZ Recall

Teva Canada Limited is voluntarily recalling Teva-Valsartan/HCTZ 80/12.5 mg, 160/12.5 mg, 160/25 mg and 320/12.5 mg tablets. Teva Canada is proceeding with a Type I recall of the lot numbers noted above to the Retail Level with the knowledge of Health Canada.

See the product, DIN and Lot from the Recall Notice below:
​
​http://www.rxbriefcase.com/rxNow/Archive/Teva/16317_ad_2018%2008%2017%20Teva-Valsartan%20HCTZ_Recall%20Bulletin_Retail_ENG.pdf